PAHO is implementing the Global Initiative on Childhood Cancer 👦👧👦 to prioritize and strengthen the countries’ capa… twitter.com/i/web/status/1…
Because while expanding regional pharmaceutical manufacturing will require significant investment, the cost 💰 of in… twitter.com/i/web/status/1…
We are counting on the support of Member States, financing institutions and others to prioritize investments in our… twitter.com/i/web/status/1…
✳️ Applications are open until October 15, and we encourage suppliers across our region to apply.
There are many steps to making vaccines 💉, so we are also inviting public and private pharmaceutical manufacturers… twitter.com/i/web/status/1…
All vaccines 💉 produced under this initiative will be available to all countries in Latin America and the Caribbean… twitter.com/i/web/status/1…
Both institutions have a long track record of vaccine manufacturing 📦 and will build on this legacy to protect peop… twitter.com/i/web/status/1…
This is a strategic initiative because mRNA technology can also be used to develop other virus vaccines 💉 for relev… twitter.com/i/web/status/1…
…– to receive technical support from PAHO and WHO to accelerate the development and production of mRNA vaccines 💉… twitter.com/i/web/status/1…
… – the public producer Bio-Manguinhos Institute of Technology on Immunobiologicals at the Oswaldo Cruz Foundatio… twitter.com/i/web/status/1…
